muscular dystrophy gene therapy - Search News

Order byBest matchMost fresh

News

FDA Will Ask Sarepta to Halt Gene Therapy Shipments

· 1h · on MSN

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators

Continue reading

Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy

MedPage Today · 23h

Drugmaker Refuses FDA's Request to Pull Gene Therapy Tied to Patient Deaths

1don MSN

FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

Patient dies in Sarepta gene therapy trial, adding to safety concerns

A 51-year-old man died last month after receiving an experimental treatment from Sarepta, the third death this year tied to ...

Muscular Dystrophy News5d

Dosing begins in gene therapy trial for DMD-linked heart disease

The first patient has been dosed in a clinical trial testing Sardocor's one-time gene therapy for cardiomyopathy associated ...

Sarepta Tags DMD Gene Therapy Elevidys With Black Box Warning, Axes 500 Staff

Following the death of two teenage patients with Duchenne muscular dystrophy following Elevidys treatment, Sarepta ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results